Track the 精华制药 share price and the full insider trade history of the company, a listed equity based in China. Shares are listed on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 精华制药 has recorded 2 reports. Market capitalisation: €5.6bn. The latest transaction was filed on 24 May 2022 (Purchase). Among the most active insiders: 薛倩玉. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Jinghua Pharmaceutical is a company focused on the manufacturing of pharmaceutical products. It is listed on the XSHE market.